Human Metapneumovirus (hMPV) can be deadly in extreme cases but unlike other similar illnesses, there is no vaccine for it.
A proof-of-concept study promises the speedy diagnosis of lower respiratory tract infections through analysis of human breath. The work is published in PNAS Nexus.
MILLIONS of Brits have been urged to book a lifesaving new jab that offers 86 per cent protection against a killer lung ...
A proof-of-concept study promises the speedy diagnosis of lower respiratory tract infections through analysis of human breath.
General Secretary Sitaram Yechury's health condition has been termed critical as he receives treatment for acute respiratory ...
Older people should take a new vaccine to protect them against Respiratory Syncytial Virus (RSV), according to new research ...
Over half of healthy U.S. infants contract RSV in their first year, according to a Vanderbilt University Medical Center study ...
A proof-of-concept study promises the speedy diagnosis of lower respiratory tract infections through analysis of human breath ...
More than half of healthy term infants born in the United States are infected with respiratory syncytial virus (RSV) during ...
Unlike acute respiratory viral infection (ARVI), influenza starts suddenly. Andrei Pozdnyakov, infectious disease specialist, ...
Impact Respiratory RNA Virus Diseases' and the rapidly evolving subject area, we are pleased to launch Volume II for this ...
Objective To explore associations between maternal body mass index (BMI) in early pregnancy and childhood infections. Design Birth cohort study linked to primary care records. Setting Bradford, UK.